1. Home
  2. INLX vs COCP Comparison

INLX vs COCP Comparison

Compare INLX & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellinetics Inc.

INLX

Intellinetics Inc.

N/A

Current Price

$3.74

Market Cap

21.6M

Sector

Technology

ML Signal

N/A

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

N/A

Current Price

$1.00

Market Cap

19.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INLX
COCP
Founded
1996
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.6M
19.2M
IPO Year
2013
2011

Fundamental Metrics

Financial Performance
Metric
INLX
COCP
Price
$3.74
$1.00
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $8.00
AVG Volume (30 Days)
21.9K
★ 32.8K
Earning Date
11-12-2026
11-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 54.65
EPS
N/A
★ N/A
Revenue
$11,336.00
★ $12,712,091.00
Revenue This Year
$14.57
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.75
$0.76
52 Week High
$9.19
$2.03

Technical Indicators

Market Signals
Indicator
INLX
COCP
Relative Strength Index (RSI) 33.83 46.87
Support Level N/A $0.97
Resistance Level $5.80 $1.10
Average True Range (ATR) 0.26 0.06
MACD -0.01 0.01
Stochastic Oscillator 11.76 35.00

Price Performance

Historical Comparison
INLX
COCP

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Software and Document Services. The Software segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Services offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Services Segment.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influenza candidate. The company has pipeline products for diseases like : Influenza, Norovirus, Coronavirus, Respiratory Viruses, and Hepatitis C.

Share on Social Networks: